Literature DB >> 10096778

Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas.

C E Mogensen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10096778     DOI： 10.1007/s001250051151

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  49 in total

1.  The impact of antihypertensive drug groups on urinary albumin excretion in a non-diabetic population.

Authors:  Taco B M Monster; Wilbert M T Janssen; Paul E de Jong; Lolkje T W de Jong-van den Berg
Journal:  Br J Clin Pharmacol       Date:  2002-01       Impact factor: 4.335

Review 2.  Management of diabetic nephropathy.

Authors:  L Foggensteiner; S Mulroy; J Firth
Journal:  J R Soc Med       Date:  2001-05       Impact factor: 5.344

3.  Electrophoretic analysis of urinary proteins in diabetic adolescents.

Authors:  G Koliakos; F Papachristou; M Papadopoulou; V Trachana; M Gaitatzi; I Sotiriou
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

Review 4.  Microvascular disease in children and adolescents with type 1 diabetes and obesity.

Authors:  M Loredana Marcovecchio; Francesco Chiarelli
Journal:  Pediatr Nephrol       Date:  2010-08-19       Impact factor: 3.714

Review 5.  Integrating albuminuria and GFR in the assessment of diabetic nephropathy.

Authors:  George Jerums; Sianna Panagiotopoulos; Erosha Premaratne; Richard J MacIsaac
Journal:  Nat Rev Nephrol       Date:  2009-07       Impact factor: 28.314

6.  Non-albuminuric renal impairment is a strong predictor of mortality in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicentre study.

Authors:  Giuseppe Penno; Anna Solini; Emanuela Orsi; Enzo Bonora; Cecilia Fondelli; Roberto Trevisan; Monica Vedovato; Franco Cavalot; Olga Lamacchia; Marco Scardapane; Antonio Nicolucci; Giuseppe Pugliese
Journal:  Diabetologia       Date:  2018-07-21       Impact factor: 10.122

Review 7.  C-peptide: a new potential in the treatment of diabetic nephropathy.

Authors:  J Wahren; K Ekberg; B Samnegård; B L Johansson
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

8.  LR-90 a new advanced glycation endproduct inhibitor prevents progression of diabetic nephropathy in streptozotocin-diabetic rats.

Authors:  J L Figarola; S Scott; S Loera; C Tessler; P Chu; L Weiss; J Hardy; S Rahbar
Journal:  Diabetologia       Date:  2003-07-05       Impact factor: 10.122

Review 9.  Diabetic nephropathy.

Authors:  Michael Shlipak
Journal:  BMJ Clin Evid       Date:  2009-01-14

10.  Long-term effect of modification of dietary protein intake on the progression of diabetic nephropathy: a randomised controlled trial.

Authors:  D Koya; M Haneda; S Inomata; Y Suzuki; D Suzuki; H Makino; K Shikata; Y Murakami; Y Tomino; K Yamada; S I Araki; A Kashiwagi; R Kikkawa
Journal:  Diabetologia       Date:  2009-08-04       Impact factor: 10.122
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.